Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Tlemsani

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Human Genetics : EJHG|May 6, 2025
Predisposition to prostate cancer and clinical implications in a real-life cohortJulie Chartier, Albain Chansavang, Anne Jouinot, et al.
Thyroid : Official Journal of the American Thyroid Association|July 26, 2022
Possible Primary Thyroid Nuclear Protein in Testis Carcinomas with <i>NSD3::NUTM1</i> Translocation Revealed by RNA Sequencing: A Report of Two CasesNoémie Scherman, Johanna Wassermann, Camille Tlemsani, et al.
Expert Opinion on Investigational Drugs|January 21, 2015
Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeuticsJennifer Arrondeau, Olivier Huillard, Camille Tlemsani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 30, 2024
Pulmonary metastasectomy for sarcoma: Insights from a referral-center cohortThomas Charrier, Edouard-Frédéric Robin, Vincent De Pauw, et al.
JCO Precision Oncology|June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni SyndromeMichele Bottosso, Benjamin Verret, Olivier Caron, et al.
Journal of Medical Genetics|October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic optionsCamille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Pharmaceutics|June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma PatientsMarie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Familial Cancer|May 19, 2024
A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysisAdrien Mouren, Albain Chansavang, Nadim Hamzaoui, et al.
Bulletin Du Cancer|April 11, 2025
[Recurrent or refractory Osteosarcoma and Ewing sarcoma-French guidelines from the FSG/NETSARC and GroupOs groups]Mehdi Brahmi, Maud Toulmonde, Sarah Winter, et al.
Bulletin Du Cancer|February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Human Genetics : EJHG|May 6, 2025
Predisposition to prostate cancer and clinical implications in a real-life cohortJulie Chartier, Albain Chansavang, Anne Jouinot, et al.
Thyroid : Official Journal of the American Thyroid Association|July 26, 2022
Possible Primary Thyroid Nuclear Protein in Testis Carcinomas with <i>NSD3::NUTM1</i> Translocation Revealed by RNA Sequencing: A Report of Two CasesNoémie Scherman, Johanna Wassermann, Camille Tlemsani, et al.
Expert Opinion on Investigational Drugs|January 21, 2015
Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeuticsJennifer Arrondeau, Olivier Huillard, Camille Tlemsani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 30, 2024
Pulmonary metastasectomy for sarcoma: Insights from a referral-center cohortThomas Charrier, Edouard-Frédéric Robin, Vincent De Pauw, et al.
JCO Precision Oncology|June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni SyndromeMichele Bottosso, Benjamin Verret, Olivier Caron, et al.
Journal of Medical Genetics|October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic optionsCamille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Pharmaceutics|June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma PatientsMarie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Familial Cancer|May 19, 2024
A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysisAdrien Mouren, Albain Chansavang, Nadim Hamzaoui, et al.
Bulletin Du Cancer|April 11, 2025
[Recurrent or refractory Osteosarcoma and Ewing sarcoma-French guidelines from the FSG/NETSARC and GroupOs groups]Mehdi Brahmi, Maud Toulmonde, Sarah Winter, et al.
Bulletin Du Cancer|February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
Pageof 6